Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bromhexine hydrochloride - WanBangDe Pharmaceutical Group

Next Previous
X
Search
Drug Profile

Bromhexine hydrochloride - WanBangDe Pharmaceutical Group

Latest Information Update: 28 Mar 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator WanBangDe Pharmaceutical Group Co., Ltd.
  • Class Aniline compounds; Antibronchitics; Antivirals; Benzene derivatives; Cyclohexylamines; Expectorants; Mucolytics; Small molecules
  • Mechanism of Action Antioxidants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported COVID-19 pneumonia

Most Recent Events

  • 28 Mar 2023 No recent reports of development identified for clinical-Phase-Unknown development in COVID-19 pneumonia in China (PO, Tablet)
  • 17 Dec 2020 Wanbangde Pharmaceutical plans a phase I trial for COVID-19 pneumonia (In volunteers) (PO, Tablet) in December 2021 (NCT04672707)
  • 16 Feb 2020 Clinical trials in COVID-19 pneumonia in China (PO) (NCT04273763)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top